A Anthralin, Dithranol CEP of the European Pharmacopoeia monograph is often referred to as a Anthralin, Dithranol Certificate of Suitability (COS). The purpose of a Anthralin, Dithranol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Anthralin, Dithranol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Anthralin, Dithranol to their clients by showing that a Anthralin, Dithranol CEP has been issued for it. The manufacturer submits a Anthralin, Dithranol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Anthralin, Dithranol CEP holder for the record. Additionally, the data presented in the Anthralin, Dithranol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Anthralin, Dithranol DMF.
A Anthralin, Dithranol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Anthralin, Dithranol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Anthralin, Dithranol suppliers with CEP (COS) on PharmaCompass.